Insulet | PODD - Ebitda





Ebitda Veränderung Datum
Abbott USD 2.43B 844M 2026-03
Align Technology USD 229.14M 31.74M 2026-03
AtriCure USD 27.28M 10.21M 2026-06
Baxter International USD 309M 756M 2026-03
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Boston Scientific USD 1.63B 27M 2026-06
Cardinal Health USD 1.09B 109M 2026-03
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Globus Medical USD 279.84M 48.01M 2026-06
ICU Medical USD 110.03M 11.35M 2026-06
Insulet USD 199.8M 18.1M 2026-06
Integra LifeSciences USD 78.41M 2.23M 2026-06
J&J USD 8.27B 1.08B 2026-03
Medtronic USD 2.81B 119M 2026-03
Merit Medical Systems USD 104.39M 10.97M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Solventum Corp USD 670M 233M 2026-06
Stryker USD 1.93B 357M 2026-06
Tandem Diabetes Care USD 6.42M 3.69M 2026-06
Teleflex USD 75.63M 171.44M 2026-03
West Pharmaceutical Services USD 243.6M 17.4M 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06